A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Italian midfielder Alessandro Florenzi was booked after celebrating a goal with a hug from his grandmother.
Charlo Greene announced her resignation as a reporter on Alaskan network KTVA live on-air with some choice language.
Watch the amazing moment a cyclist in Russia escapes being killed as a truck and car collide at high speed.